Who
Brent L. Saunders
Chairman of the Board and CEO
Company insider
Files Form 4 as: Chairman of the Board and CEO, Bausch + Lomb; Director, ARS Pharmaceuticals; Executive Chairman, SkinHealth Systems; Director, Cisco Systems; Director, BridgeBio Pharma; Chairman, President and CEO, Allergan; CEO & President, Forest Laboratories; Senior Vice President, Merck & Company.
In numbers
- Trades disclosed
- 177
- Buys
- 13
- Sells
- 2
- Bought
- $4.7M
- Sold
- $2.8M
- Companies
- 8
- Companies where not an officer
- 3
- First trade
- 19 May 2006
- Last trade
- 5 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Aug 2026filed 7 Aug 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $71K4,231 at $16.76 | filing |
| 5 Aug 2026filed 7 Aug 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —281,879 at $0.00 | filing |
| 5 Aug 2026filed 7 Aug 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $71K4,231 at $16.76 | filing |
| 5 Aug 2026filed 7 Aug 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —281,879 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | SPRY ARS Pharmaceuticalsoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $46K2,886 at $15.92 | filing |
| 22 May 2026filed 26 May 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $46K2,886 at $15.92 | filing |
| 6 Mar 2026filed 10 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Bought | $252K14,700 at $17.14 | filing |
| 6 Mar 2026filed 10 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —14,700 at $0.00 | filing |
| 6 Mar 2026filed 10 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Bought | $252K14,700 at $17.14 | filing |
| 6 Mar 2026filed 10 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —14,700 at $0.00 | filing |
| 27 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $451K24,649 at $18.30 | filing |
| 27 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $451K24,649 at $18.30 | filing |
| 26 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $408K22,059 at $18.49 | filing |
| 26 Feb 2026filed 2 Mar 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $408K22,059 at $18.49 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —327,102 at $0.00 | filing |
| 25 Feb 2026filed 27 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code A | —327,102 at $0.00 | filing |
| 23 Feb 2026filed 25 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $1.2M65,444 at $17.99 | filing |
| 23 Feb 2026filed 25 Feb 2026 | BLCO Bausch + LombMedical Devices | SEC FORM 4 Code F | $1.2M65,444 at $17.99 | filing |
News
Verily Health, Bausch + Lomb partner to bring dry eye care to appBLCO · healio.com · 15 Oct 2026Bausch + Lomb (NYSE:BLCO) Stock Price Down 5.8% – Here's What HappenedBLCO · dailypolitical.com · 14 Oct 2026Barclays Upgrades Bausch + Lomb (NYSE:BLCO) to "Strong-Buy"BLCO · dailypolitical.com · 9 Oct 2026
0 headlines in the last 90 days name Brent L. Saunders; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.